Amanote Research
Register
Sign In
P1.14-11 the Expression Pattern of Programmed Death-Ligand 1 According to the Pathological Type of Malignant Thymic Epithelial Tumors
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.913
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
S. Ishihara
S. Okada
H. Ogi
Y. Kodama
K. Itoh
A. Marx
M. Inoue
Publisher
Elsevier BV
Related search
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
Frontiers in Oncology
Cancer Research
Oncology
Evaluation of the Malignant Grade of Thymic Epithelial Tumors According to the Epithelial Subclassification
Surgery Today
Medicine
Surgery
Programmed Death Ligand 1 (PD-L1) Expression in Epithelial Ovarian Cancer: A Comparison of Type I and Type II Tumors
Asian Pacific Journal of Cancer Prevention
P1.14-21 Circulating Biomarkers in Thymic Epithelial Tumors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.14-16 DNA Methylation of GNG4、GHSR、HOXD9 and SALL3 Genes Predict Malignant Behavior of Thymic Epithelial Tumors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.14-20 the Expression of DNA Methylation of GAD1 Gene Is an Indicator of Malignant Behavior in Thymic Epithelial Tumor
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
Journal of Cancer
Oncology
Relative Efficacy of Checkpoint Inhibitors for Advanced NSCLC According to Programmed Death-Ligand-1 Expression: A Systematic Review and Network Meta-Analysis
Scientific Reports
Multidisciplinary
Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
Clinical Cancer Research
Cancer Research
Oncology
